A total scale of 30 billion! The first national-level mother fund in the foreign trade and economic field is being raised, introducing listed company LP Jinbo Bio and Joinn Laboratories.
① The Innovation and Development Guidance Fund for Service Trade is a national-level fund initiated by the Ministry of Finance, the Ministry of Commerce, and China Merchants Group, approved by the State Council, with a total scale of 30 billion yuan. ② An IR practitioner stated to the Star Daily that the second phase of the service trade fund inviting listed companies to become LPs may be a more market-oriented signal.
Daily Bull and Bear | Market sentiment is warming up! The Hang Seng Index futures closed above 21,000 points, with the bull certificate ratio regaining the advantage; the Hong Kong Stock Exchange rose nearly 6% yesterday, with multiple call warrants makin
As of market close, the total market turnover was 206.53 billion HKD, with trading sentiment showing some improvement; the total turnover of all warrants and callable bull/bear contracts was 12.633 billion HKD, accounting for 6.1% of the total market turnover, of which the long positions accounted for 3.8% and the short positions accounted for 2.4%.
0.15 billion! Wuxi AppTec invested in a French VC, adding to the European biomedical market.
① Wuxi Apptec plans to invest in the "Jeito II S.L.P." fund, with a total target scale not exceeding 1.2 billion euros, and the fund is expected to invest in 14-17 medical innovative startups. ② Previously, Wuxi Apptec planned to invest 10 million euros in another well-known biotechnology investment institution in Europe, focusing on early-stage biomedical companies in Europe.
Futu Morning Post | Senior officials at the Federal Reserve support cautious rate cuts! Hawks directors say inflation progress seems to have stalled; S&P, Nasdaq hit new highs again, AI application stocks collectively surged, and Tesla has risen more than
A conclusion! The final version of the NDAA from both chambers of Congress did not include the biosecurity bill; at the Tesla investor meeting: new models will be launched in the first half of 2025, with an annual sales growth target of 20-30%, computing power will significantly enhance FSD, and there are no competitors for autonomous driving in Europe and the US; included in the s&p 500 index! apollo global management and Workday surged collectively after hours.
The chapter comes to a close! The final version of the NDAA in both the House and Senate did not include the biological security bill. Will it make a comeback next year?
1. The final negotiation text of NDAA did not include the "Biosecurity Act", and the attempt to "ride on the coattails" failed again; 2. This year, the session of the US Congress will come to an end, experts believe that the legislation of the "Biosecurity Act" this year may come to a conclusion, but it may "come back with a vengeance" next year.
How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.
① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.